Dongxing Zha, Ph.D.
Dongxing Zha, Ph.D.
Dongxing Zha, Ph.D., is a seasoned drug development leader dedicated to the translation of immune-oncology discoveries into innovative anti-cancer therapies. He leads the Oncology Research for Biologics and Immunotherapy Translation (ORBIT) platform, which is a unique group of clinicians, researchers and drug development experts working collaboratively to develop biologic and cell-based therapies. The ultimate goal of the ORBIT platform is to make MD Anderson the pharmaceutical partner of choice for the development of innovative biologics, which could help patients to prevail the cancer diseases.
With the ORBIT platform, we're integrating the strengths of
traditional scientific discovery from academic researchers with
industrial drug discovery expertise. The combined advantages will
accelerate the pace of translating novel discoveries from lab into
anti-cancer therapies in clinic.
I'm motivated by the opportunity to discover innovative anti-cancer therapies, and bring new treatments to patients. Our long term goal is to bring cures to cancer patients and to contribute the mission of Making Cancer History.
I would like to build a sustainable biologics discovery and
development pipeline. With this, we can continue to deliver novel
antibody discovery programs into the proof-of-biology development
stage. Then, we will collaborate with pharmaceutical partners to
translate these discoveries into new therapies to help patients to
prevail over cancers.
Cancer is a horrible disease and has affected many families and friends. My father also died of cancer, so I've joined the mission of Making Cancer History®. I'm fighting to bring cures to patients who, like my father, desperately need them.
I'm the leader of the ORBIT platform, which is designed to accelerate monoclonal antibody discovery and to translate these novel discoveries into innovative anti-cancer therapies.
Our efforts require teamwork, a lot of resources and quite a bit of
time to complete. In order to bring new therapies to patients, we need
a lot of financial help. We hope to team up with different
organizations so that together we can fight and beat cancer.